Immune checkpoint therapy in liver cancer

Immune checkpoints include stimulatory and inhibitory checkpoint molecules. In recent years, inhibitory checkpoints, including cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), programmed cell death protein-1 (PD-1), and programmed cell death ligand 1 (PD-L1), have been identified to suppress an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Feng, Jin, Tianqiang, Zhu, Yuwen, Dai, Chaoliu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975687/
https://www.ncbi.nlm.nih.gov/pubmed/29843754
http://dx.doi.org/10.1186/s13046-018-0777-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975687/
https://www.ncbi.nlm.nih.gov/pubmed/29843754
http://dx.doi.org/10.1186/s13046-018-0777-4

Ejemplares similares